Allergy and Immunology · Montgomery, AL
NPI
1225029259
Since 2005
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1420 Narrow Lane Pkwy
Montgomery, AL, 36111
Phone (334) 284-4196
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
1,923 services
Medicare patients, 2024
61
Average age 72
Drug cost, 2024
$319K
839 prescriptions
Company payments, 2025
$1,861
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Harry A Lee was code 99214 (office e&m - established), 75 times for 55 patients. In total Harry A Lee billed 1,923 services in 20 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-12-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 75 | 55 | $75.97 | $5,697 |
| 94010 Pulmonary Function Testing | Office | 44 | 34 | $16.91 | $744 |
By year: 2022 $39K for 2,234 services; 2023 $30K for 1,264 services; 2024 $51K for 1,923 services.
Medicare prescription drug claims, 2024
In 2024, the drug Harry A Lee prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 115 prescriptions and refills. In total Harry A Lee wrote 839 Medicare prescriptions that cost $319K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 115 | 115 | 21 | $74K |
| Famotidine Generic | 81 | 212 | 31 | $1,686 |
| Montelukast Sodium Generic | 79 | 236 | 28 | $1,227 |
| Zafirlukast Generic | 59 | 159 | 22 | $13K |
| Azelastine Hcl Generic | 57 | 103 | 15 | $2,060 |
| Levocetirizine Dihydrochloride Generic | 45 | 127 | 15 | $698 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 40 | 42 | 21 | $841 |
| Breo Ellipta Fluticasone/Vilanterol | 32 | 42 | Under 11 | $16K |
| Fluticasone Propionate Generic | 28 | 40 | Under 11 | $487 |
| Dupixent Syringe Dupilumab | 28 | 28 | Under 11 | $106K |
| Theophylline Er Theophylline Anhydrous | 27 | 57 | Under 11 | $968 |
| Doxycycline Hyclate Generic | 24 | 54 | 12 | $965 |
| Cimetidine Generic | 14 | 26 | Under 11 | $1,432 |
| Azithromycin Generic | 13 | 15 | Under 11 | $96.21 |
| Symbicort Budesonide/Formoterol Fumarate | 13 | 13 | Under 11 | $2,972 |
Brand drugs: 298 claims; generic drugs: 541 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Harry A Lee $1,861 ($1,861 in general payments such as food, travel and fees) from 14 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $449.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $449 |
| Regeneron Healthcare Solutions, Inc. REGN | 9 | $261 |
| GlaxoSmithKline, LLC. GSK | 11 | $225 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $188 |
| Genentech USA, Inc. ROG.SW | 6 | $175 |
| CSL Behring CSL.AX | 5 | $123 |
| Octapharma USA, Inc. | 5 | $117 |
| Amgen Inc. AMGN | 4 | $97.69 |
| Pharming Healthcare, Inc. | 3 | $82.33 |
| Pfizer Inc. PFE | 2 | $56.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.